# Utilizing surface plasmon resonance as a novel method for monitoring in-vitro P-glycoprotein efflux

**Authors:** Phuong H. Nguyen, Shuolin Cui, Amanda M. Kozarich, Alex Rautio, Arthur G. Roberts, May P. Xiong

PMC · DOI: 10.3389/frbis.2024.1367511 · 2024-04-19

## TL;DR

This study introduces a new method using surface plasmon resonance to monitor P-glycoprotein transport in real time, improving drug development testing.

## Contribution

A novel SPR-based assay for measuring P-glycoprotein efflux in real time is developed.

## Key findings

- The SPR method successfully measured transport rates of Pgp substrates like quinidine, methadone, and desipramine.
- Kinetic analysis supported the vacuum cleaner model for Pgp substrate translocation.
- The method provides real-time data in a controlled microenvironment, addressing limitations of existing techniques.

## Abstract

P-glycoprotein (Pgp) is known for its dichotomous roles as both a safeguarding efflux transporter against xenobiotics and as a catalyst for multidrug resistance. Given the susceptibility of numerous therapeutic compounds to Pgp-mediated resistance, compliance with Food and Drug Administration (FDA) guidelines mandates an in-depth in vitro transport assay during drug development. This study introduces an innovative transport assay that aligns with these regulatory imperatives but also addresses limitations in the currently established techniques. Using Pgp-reconstituted liposomes and employing surface plasmon resonance (SPR), this study developed a distinct method of measuring the relative transport rates of Pgp substrates in a controlled microenvironment. The Pgp substrates selected for this study—quinidine, methadone, and desipramine—resulted in transport ratios that corroborate with trends previously observed. To assess the kinetics of Pgp-mediated transport, the results were analyzed by fitting the data to both currently proposed Pgp substrate translocation models—the vacuum cleaner and flippase models. While the resulting kinetic analysis in this study lends support predominantly to the vacuum cleaner model, this study most notably developed a novel method of assessing Pgp-mediated transport rates and real-time kinetics using surface plasmon resonance.

## Linked entities

- **Proteins:** Mdr65 (Multi drug resistance 65), PGP (phosphoglycolate phosphatase)
- **Chemicals:** quinidine (PubChem CID 101744), methadone (PubChem CID 4095), desipramine (PubChem CID 2995)

## Full-text entities

- **Genes:** PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}
- **Diseases:** multidrug resistance (MESH:D018088)

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11027885/full.md

---
Source: https://tomesphere.com/paper/PMC11027885